Biopharmaceutical Innovation Creates New Opportunities for Biologics CDMO Providers
The global biologics contract development and manufacturing organization (CDMO) market was valued at USD 29.53 billion in 2025 and is projected to grow from USD 31.65 billion in 2026 to USD 55.90 billion by 2034, registering a CAGR of 7.37% during the forecast period (2026–2034). The market is witnessing robust growth owing to the...
0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior